139 related articles for article (PubMed ID: 37663709)
1. Relationship between metalloproteinase-9 (MMP-9) expression and clinicopathology in colorectal cancer: a cross-sectional study.
Mudatsir ; Labeda I; Uwuratuw JA; Hendarto J; Warsinggih ; Lusikooy RE; Mappincara ; Sampetoding S; Kusuma MI; Syarifuddin E; Arsyad A; Faruk M
Ann Med Surg (Lond); 2023 Sep; 85(9):4277-4282. PubMed ID: 37663709
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma.
Buhmeida A; Bendardaf R; Hilska M; Collan Y; Laato M; Syrjänen S; Syrjänen K; Pyrhönen S
J Gastrointest Cancer; 2009; 40(3-4):91-7. PubMed ID: 19921474
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.
Işlekel H; Oktay G; Terzi C; Canda AE; Füzün M; Küpelioğlu A
Cell Biochem Funct; 2007; 25(4):433-41. PubMed ID: 16615041
[TBL] [Abstract][Full Text] [Related]
4. Expression of MMP-9 and WAVE3 in colorectal cancer and its relationship to clinicopathological features.
Zhang Y; Guan XY; Dong B; Zhao M; Wu JH; Tian XY; Hao CY
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2035-44. PubMed ID: 22806308
[TBL] [Abstract][Full Text] [Related]
5. Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel.
Barozzi C; Ravaioli M; D'Errico A; Grazi GL; Poggioli G; Cavrini G; Mazziotti A; Grigioni WF
Cancer; 2002 Feb; 94(3):647-57. PubMed ID: 11857296
[TBL] [Abstract][Full Text] [Related]
6. The association between the serum levels of matrix metalloproteinase 9 and colorectal cancer.
Rašić I; Rašić A; Akšamija G; Radović S; Šehović N
Med Glas (Zenica); 2017 Aug; 14(2):229-235. PubMed ID: 28644426
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features.
Tian X; Ye C; Yang Y; Guan X; Dong B; Zhao M; Hao C
J Transl Med; 2015 Oct; 13():337. PubMed ID: 26507719
[TBL] [Abstract][Full Text] [Related]
8. High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
Peltonen R; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Isoniemi H
Oncology; 2021; 99(3):144-160. PubMed ID: 33027796
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of matrix metalloproteinase-7 in colorectal cancer.
Yang B; Su K; Gao J; Rao Z
Asian Pac J Cancer Prev; 2012; 13(3):1049-52. PubMed ID: 22631636
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
Zheng CG; Chen R; Xie JB; Liu CB; Jin Z; Jin C
Cancer Biomark; 2015; 15(6):889-97. PubMed ID: 26406415
[TBL] [Abstract][Full Text] [Related]
11. Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells.
Zeng ZS; Guillem JG
Br J Cancer; 1996 Oct; 74(8):1161-7. PubMed ID: 8883399
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and diagnostic implications of MMP-2, MMP-9, and VEGF-α expressions in colorectal cancer.
Araújo RF; Lira GA; Vilaça JA; Guedes HG; Leitão MC; Lucena HF; Ramos CC
Pathol Res Pract; 2015 Jan; 211(1):71-7. PubMed ID: 25446246
[TBL] [Abstract][Full Text] [Related]
13. The Behavior of MMP-2, MMP-7, MMP-9, and Their Inhibitors TIMP-1 and TIMP-2 in Adenoma-Colorectal Cancer Sequence.
Barabás L; Hritz I; István G; Tulassay Z; Herszényi L
Dig Dis; 2021; 39(3):217-224. PubMed ID: 32961536
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer Progression and Clinicopathological Characteristics.
Huang HC; Shiu BH; Su SC; Huang CC; Ting WC; Chang LC; Yang SF; Chou YE
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885589
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of matrix metalloproteinase 7 immunohistochemical expression in colorectal cancer: a meta-analysis.
Chen H; Hu Y; Xiang W; Cai Y; Wang Z; Xiao Q; Liu Y; Li Q; Ding K
Int J Clin Exp Med; 2015; 8(3):3281-90. PubMed ID: 26064217
[TBL] [Abstract][Full Text] [Related]
16. The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer.
Hettiaratchi A; Hawkins NJ; McKenzie G; Ward RL; Hunt JE; Wakefield D; Di Girolamo N
Br J Cancer; 2007 Mar; 96(5):783-92. PubMed ID: 17311017
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis.
Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY
Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic Role of Connective Tissue Growth Factor Is Associated with Canonical TGF-β Cascade in Colorectal Cancer.
Hosseini S; Rejali L; Pezeshkian Z; Malekian M; Fatemi N; Peyravian N; Hadizadeh M; Mohsenifar Z; Khanabadi B; Farzam M; Sherkat G; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Ashrafian Bonab M
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456495
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases 2, 7 and 9 in patients with colorectal cancer.
Kostova E; Slaninka-Miceska M; Labacevski N; Jakovski K; Trojachanec J; Atanasovska E; Janevski V; Jovanovik R; Janevska V
Vojnosanit Pregl; 2014 Jan; 71(1):52-9. PubMed ID: 24516991
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
Baker EA; Bergin FG; Leaper DJ
Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
